By comparing the expression of PD-L1 in TNBC and other breast cancers from the transcriptional as well as protein aspect, Mittendorf et al. reported that 20% of TNBC patients expressed PD-L1, which was higher than other breast cancer. The gene discussed is CD274; the disease is breast carcinoma.